Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Keizer

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|May 13, 1999
[Results of 15 years of treatment of nonseminoma testicular cancer: 84% 5-year survival rate]L R van Veelen, E W Steyerberg, F J Cleton, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Acute reversible neurotoxicity after intrathecal low-dose methotrexateD H Schweitzer, P M Edelbroek, F A de Wolff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2000
Diabetes insipidus in metastatic cancer: two case reports with review of the literatureD T Huinink, G A Veltman, T W Huizinga, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|March 7, 1997
Chromatographic analysis of the enantiomers of ifosfamide and some of its metabolites in plasma and urineG P Kaijser, J H Beijnen, A Bult, et al.
Anti-Cancer Drugs|July 11, 1998
Use of granisetron in patients refractory to previous treatment with antiemeticsJ Carmichael, H J Keizer, D Cupissol, et al.
Anticancer Research|September 1, 1996
Pharmacokinetics of ifosfamide, 2- and 3-dechloroethylifosfamide in plasma and urine of cancer patients treated with a 10-day continuous infusion of ifosfamideG P Kaijser, H J Keizer, J H Beijnen, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Ifosfamide treatment as a 10-day continuous intravenous infusionH J Keizer, J Ouwerkerk, K Welvaart, et al.
Cancer Letters|March 1, 1988
Combined effects of bromovinyldeoxyuridine and fractionated or continuous administration of 5-fluorouracil in P388 leukemia-bearing miceH J Keizer, R Pauwels, W Landuyt, et al.
Biopharmaceutics & Drug Disposition|December 18, 2001
Distribution of ifosfamide and metabolites between plasma and erythrocytesT Kerbusch, V M Herben, M J Jeuken, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 16, 2001
Influence of dose and infusion duration on pharmacokinetics of ifosfamide and metabolitesT Kerbusch, R A Mathôt, H J Keizer, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Nederlands Tijdschrift Voor Geneeskunde|May 13, 1999
[Results of 15 years of treatment of nonseminoma testicular cancer: 84% 5-year survival rate]L R van Veelen, E W Steyerberg, F J Cleton, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Acute reversible neurotoxicity after intrathecal low-dose methotrexateD H Schweitzer, P M Edelbroek, F A de Wolff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2000
Diabetes insipidus in metastatic cancer: two case reports with review of the literatureD T Huinink, G A Veltman, T W Huizinga, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|March 7, 1997
Chromatographic analysis of the enantiomers of ifosfamide and some of its metabolites in plasma and urineG P Kaijser, J H Beijnen, A Bult, et al.
Anti-Cancer Drugs|July 11, 1998
Use of granisetron in patients refractory to previous treatment with antiemeticsJ Carmichael, H J Keizer, D Cupissol, et al.
Anticancer Research|September 1, 1996
Pharmacokinetics of ifosfamide, 2- and 3-dechloroethylifosfamide in plasma and urine of cancer patients treated with a 10-day continuous infusion of ifosfamideG P Kaijser, H J Keizer, J H Beijnen, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Ifosfamide treatment as a 10-day continuous intravenous infusionH J Keizer, J Ouwerkerk, K Welvaart, et al.
Cancer Letters|March 1, 1988
Combined effects of bromovinyldeoxyuridine and fractionated or continuous administration of 5-fluorouracil in P388 leukemia-bearing miceH J Keizer, R Pauwels, W Landuyt, et al.
Biopharmaceutics & Drug Disposition|December 18, 2001
Distribution of ifosfamide and metabolites between plasma and erythrocytesT Kerbusch, V M Herben, M J Jeuken, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 16, 2001
Influence of dose and infusion duration on pharmacokinetics of ifosfamide and metabolitesT Kerbusch, R A Mathôt, H J Keizer, et al.
Pageof 7